Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors
This study has been completed.
Study NCT00024661   Information provided by Neopharm
First Received: September 24, 2001   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neoplasms
Interventions listed in this trial
LErafAON
Sponsors listed in this trial
Neopharm
Georgetown University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services